Comparison of 3 guideline lipid emulsion regimens for local anesthetic systemic toxicity: an in silico study of bolus duration, total dose, and treatment delay in intravenous bupivacaine overdose.
Oct 2026· Ewha Medical Journal· 0 citations· 31 references
Medicine
TL;DR
In this bupivacaine model, bolus duration distinguished the regimens more than dose did, and delay had a greater effect than either, eliminating most of the benefit without changing the lipid load.
Abstract
Purpose
Lipid emulsion is the only specific antidote for local anesthetic systemic toxicity, but no dose-finding study has been conducted. We compared 3 published regimens and alternative schedules that deliver the same dose in different ways using a human model of intravenous bupivacaine overdose.
Methods
A 14-compartment human bupivacaine model was independently reimplemented without fitted parameters, replacing first-order lipid elimination with a saturable term. Toxicity was modeled as 112.5 mg administered intravenously over 3 minutes. Benefit was defined as the predicted maximum decrease in myocardial bupivacaine within 30 minutes, and harm as the predicted relative lipid load, indexed by peak plasma triglyceride concentration. Neither measure is a validated surrogate.
Results
The 3 guidelines specify the same doses but different bolus durations: 1 minute versus 2-3 minutes. At a matched dose of 12 mL/kg, myocardial bupivacaine decreased by 30.5% with the 1-minute bolus and 24.9% with the 2.5-minute bolus, with the same lipid load. The completed American Society of Regional Anesthesia and Pain Medicine regimen (7.64 mL/kg) achieved a 24.6% decrease versus 24.9% with 12 mL/kg; thus, complete regimens differ in schedule as well as dose. Repeating the 1-minute bolus twice, for a total of 4.5 mL/kg, achieved a 31.9% decrease with 62% less emulsion. Start time had the greatest effect: the best regimen achieved a 41.8% decrease when started at the end of the injection, but only 9.6% when started at 10 minutes.
Conclusion
In this bupivacaine model, bolus duration distinguished the regimens more than dose did, and delay had a greater effect than either, eliminating most of the benefit without changing the lipid load. Treatment should begin at the first signs of toxicity, and 20% lipid emulsion should be immediately available wherever local anesthetics are used.
Solubilizing propofol without lipid-associated risks-hyperlipidemia, microbial growth, and severe injection pain-remains a major formulation challenge spanning over four decades. Traditional lipid emulsions persist largely due to the difficulty of achieving high-capacity aqueous solubilization without compromising safe...
N. Wu, Fang R. Teng· Journal of Pharmacy and Scie...· 0 citations
There is no difference between the use of low doses and standard doses of SO-ILE in neonates receiving parenteral nutrition with respect to liver-related, growth, or mortality outcomes.
Nágila Alves Lima, Jennifer Brito Warner, L. R. Campos et al.· JPEN - Journal of Parenteral...· 0 citations
Diclofenac is a widely used topical nonsteroidal anti-inflammatory drug (NSAID) for pain and inflammation. This study evaluated the relative bioavailability of diclofenac from diclofenac sodium (DS) gel 1% versus diclofenac diethylamine (DEA) gel 1.16% and assessed whether adjunct heat or moderate exercise influences s...
Karin Nicholson, M. Armogida, M. Gold et al.· Clinical pharmacology in dru...· 0 citations
BACKGROUND
Cutaneous pharmacokinetics (PK) can be assessed using dermal open flow microperfusion (dOFM) and dermal microdialysis (dMD). However, the dermal vasculature can clear and redistribute compounds to the skin, which may affect an assessment of bioequivalence (BE).
OBJECTIVE
This study verified the BE of a top...
K. Tiffner, T. Ramezanli, Beate Boulgaropoulos et al.· European Journal of Pharmace...· 0 citations
The charcoal-related findings are consistent with, but do not establish, a predominant pulmonary contribution to systemic exposure after nebulization and should be interpreted cautiously because the conditions were evaluated in separate cohorts.
Yin-Juan Li, L. Qi, Rong-Xia Fan et al.· Journal of Pharmacy & Pharma...· 0 citations
Background/Objectives: Real-world data on intravenous fat emulsion administration and postoperative lipid profiles under standardized clinical pathways are limited. We described administration practices and short-term lipid profiles after gastrectomy. Methods: This single-center retrospective study included patients wh...
Kazuo Kobayashi, S. Ida, Masanari Tsuji et al.· Nutrients· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.